Literature DB >> 29871910

Lgl reduces endosomal vesicle acidification and Notch signaling by promoting the interaction between Vap33 and the V-ATPase complex.

Marta Portela1,2,3, Liu Yang4, Sayantanee Paul4, Xia Li5, Alexey Veraksa4, Linda M Parsons2,6, Helena E Richardson7,2,8.   

Abstract

Epithelial cell polarity is linked to the control of tissue growth and tumorigenesis. The tumor suppressor and cell polarity protein lethal-2-giant larvae (Lgl) promotes Hippo signaling and inhibits Notch signaling to restrict tissue growth in Drosophila melanogaster Notch signaling is greater in lgl mutant tissue than in wild-type tissue because of increased acidification of endosomal vesicles, which promotes the proteolytic processing and activation of Notch by γ-secretase. We showed that the increased Notch signaling and tissue growth defects of lgl mutant tissue depended on endosomal vesicle acidification mediated by the vacuolar adenosine triphosphatase (V-ATPase). Lgl promoted the activity of the V-ATPase by interacting with Vap33 (VAMP-associated protein of 33 kDa). Vap33 physically and genetically interacted with Lgl and V-ATPase subunits and repressed V-ATPase-mediated endosomal vesicle acidification and Notch signaling. Vap33 overexpression reduced the abundance of the V-ATPase component Vha44, whereas Lgl knockdown reduced the binding of Vap33 to the V-ATPase component Vha68-3. Our data indicate that Lgl promotes the binding of Vap33 to the V-ATPase, thus inhibiting V-ATPase-mediated endosomal vesicle acidification and thereby reducing γ-secretase activity, Notch signaling, and tissue growth. Our findings implicate the deregulation of Vap33 and V-ATPase activity in polarity-impaired epithelial cancers.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29871910      PMCID: PMC6437781          DOI: 10.1126/scisignal.aar1976

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  118 in total

1.  Ligand-induced cleavage and regulation of nuclear entry of Notch in Drosophila melanogaster embryos.

Authors:  S Kidd; T Lieber; M W Young
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

Review 2.  Role of vacuolar-type proton ATPase in signal transduction.

Authors:  Ge-Hong Sun-Wada; Yoh Wada
Journal:  Biochim Biophys Acta       Date:  2015-06-11

3.  aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia.

Authors:  D Grifoni; F Garoia; P Bellosta; F Parisi; D De Biase; G Collina; D Strand; S Cavicchi; A Pession
Journal:  Oncogene       Date:  2007-03-19       Impact factor: 9.867

4.  Lgl regulates Notch signaling via endocytosis, independently of the apical aPKC-Par6-Baz polarity complex.

Authors:  Linda M Parsons; Marta Portela; Nicola A Grzeschik; Helena E Richardson
Journal:  Curr Biol       Date:  2014-09-11       Impact factor: 10.834

5.  Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors.

Authors:  Gongping Sun; Kenneth D Irvine
Journal:  Dev Biol       Date:  2010-12-09       Impact factor: 3.582

6.  A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism.

Authors:  Anuradha Ratnaparkhi; George M Lawless; Felix E Schweizer; Peyman Golshani; George R Jackson
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

7.  The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma.

Authors:  Andrea Di Cristofori; Stefano Ferrero; Irene Bertolini; Gabriella Gaudioso; Maria Veronica Russo; Valeria Berno; Marco Vanini; Marco Locatelli; Mario Zavanone; Paolo Rampini; Thomas Vaccari; Manuela Caroli; Valentina Vaira
Journal:  Oncotarget       Date:  2015-07-10

8.  Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.

Authors:  Matthew McConnell; Shengmei Feng; Wei Chen; Guochun Zhu; Dejun Shen; Selvarangan Ponnazhagan; Lianfu Deng; Yi-Ping Li
Journal:  Oncotarget       Date:  2017-07-18

9.  Molecular cloning of lethal(2)giant larvae, a recessive oncogene of Drosophila melanogaster.

Authors:  B M Mechler; W McGinnis; W J Gehring
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

10.  2016 update of the PRIDE database and its related tools.

Authors:  Juan Antonio Vizcaíno; Attila Csordas; Noemi del-Toro; José A Dianes; Johannes Griss; Ilias Lavidas; Gerhard Mayer; Yasset Perez-Riverol; Florian Reisinger; Tobias Ternent; Qing-Wei Xu; Rui Wang; Henning Hermjakob
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971

View more
  5 in total

1.  MiR-16-5p suppresses myofibroblast activation in systemic sclerosis by inhibiting NOTCH signaling.

Authors:  Qicen Yao; Yixi Xing; Zaiyan Wang; Jin Liang; Qianqi Lin; Meiqiong Huang; Yiling Chen; Bo Lin; Xiayu Xu; Weifei Chen
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

2.  Evidence for a nuclear role for Drosophila Dlg as a regulator of the NURF complex.

Authors:  Katherine A Sharp; Mark J Khoury; Frederick Wirtz-Peitz; David Bilder
Journal:  Mol Biol Cell       Date:  2021-09-08       Impact factor: 4.138

Review 3.  Drosophila as a Model for Developmental Biology: Stem Cell-Fate Decisions in the Developing Nervous System.

Authors:  Katherine Harding; Kristin White
Journal:  J Dev Biol       Date:  2018-10-19

Review 4.  Notch Transduction in Non-Small Cell Lung Cancer.

Authors:  Amnah Sharif; Ann Shaji; May Chammaa; Eileen Pawlik; Rodrigo Fernandez-Valdivia
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

Review 5.  The Role of Intracellular Trafficking of Notch Receptors in Ligand-Independent Notch Activation.

Authors:  Judith Hounjet; Marc Vooijs
Journal:  Biomolecules       Date:  2021-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.